ASHPOfficial

In this episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with ASHP President Tom Johnson about transformational presence — the concept of self-awareness and observing what is going on around you. The ASHP leaders share ways pharmacy practitioners can use transformational presence to embrace change to advance the profession.  

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Patients with opioid use disorder (OUD) require close monitoring and consistent access to care. This podcast focuses on providing care to this patient population during the COVID-19 pandemic. For more information on the pharmacist’s role in the management of OUD during the COVID-19 pandemic, as well as resources from the National Academy of Medicine Action Collaborative on Countering the US Opioid Epidemic, please see the full webinar recording at ASHP elearning.org.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP and Accreditation Services is monitoring the current COVID-19 pandemic and managing, to the extent possible, disruptions to residency training and accreditation activities. ASHP is committed to supporting pharmacy residency programs during this unprecedented time. Part 2 of this podcast will describe the program completion, onboarding/orientation process, as well as recruitment/interviews of two pharmacy residency programs in different parts of the US. To hear more about their experiences, please see the full webinar recording at ASHP elearning.org

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP and Accreditation Services is monitoring the current COVID-19 pandemic and managing, to the extent possible, disruptions to residency training and accreditation activities. ASHP is committed to supporting pharmacy residency programs during this unprecedented time. Part 1of this podcast will describe the unanticipated challenges and unique opportunities of two pharmacy residency program directors in different parts of the US. To hear more about their experiences, please see the full webinar recording at ASHP elearning.org.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

Dr. Yen H. Dang and Dr. Kim P. To-Lui discuss with William Zellmer, Contributing Editor for AJHP, results from a survey study conducted to assess pharmacist views on postgraduate year 3 training. The article under discussion will appear in the September 15, 2020, issue of AJHP.

Recorded July 15, 2020.

AJHP is the official journal of the American Society of Health-System Pharmacists.

www.ajhpvoices.org

Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio,  Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. To learn more about the list visit https://www.cdc.gov/niosh/topics/hazdrug/default.html.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join members of the ASHP New Practitioners Forum Clinical Practice Advisory Group as they share advice for student pharmacists, pharmacy residents and new practitioners on tips and tricks for staying updated on best practices and review of the literature.

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

 

Continuous Glucose Monitors (CGMs) are quickly becoming a popular substitute for glucometers and avoid the need for frequent finger sticks to determine glucose values in patients with diabetes.  This podcast will share the experiences of two ambulatory care clinical pharmacists that have incorporated CGMs into their clinical practice. 

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

 

As the opioid crisis continues to affect the lives of people around the country health-systems most impacted by the crisis have taken a proactive approach in the fight. Recognizing the need for grassroots leadership to guide responsible opioid prescribing the University of Kentucky HealthCare implemented an Opioid Stewardship Program.

 

The host and speakers would like to give special acknowledgement of Steven Silverstein, Pharm.D., BCPS, Director of Pharmacy; Mercy Hospital and Medical Center, Chicago, IL for his assistance with the development of this podcast.

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In the wake of drug shortages, patients with a high requirement for sedation coupled with an increase in the number of patients who have renal failure due to complications to COVID-19, pharmacists must be ever vigilant on managing patient’s mediation regimens and monitoring for toxicities.  With that in mind, we sit down with our content matter experts to talk about managing patients who might be at risk for developing toxicities due to the excipients found in drugs and how pharmacists can play an important role in preventing these adverse events. 

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.